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Abstract
Background: Previous studies have shown an association between diabetes mellitus (DM) and
urinary incontinence (UI) in women, especially severe UI. The purpose of this study was to
investigate whether diabetes related variables could explain this association.
Methods: The study is part of the EPINCONT study, which is based on the large Nord-Trøndelag
Health Study 2 (HUNT 2), performed in the county of Nord-Trøndelag, Norway, during the years
1995 - 1997. Questions on diabetes and UI were answered by a total of 21 057 women aged 20
years and older. Of these 685 were identified as having diabetes, and thus comprise the population
of our study. A variety of clinical and biochemical variables were recorded from the participants.
Results: Blood-glucose, HbA1c, albumine:creatinine ratio (ACR), duration of diabetes, diabetes
treatment, type of diabetes, cholesterol and triglycerides did not significantly differ in women with
and without UI in crude analyses. However, the diabetic women with UI had more hospitalizations
during the last 12 months, more homecare, and a higher prevalence of angina and use of oestrogene
treatment (both local and oral/patch). After adjusting for age, BMI, parity and smoking, there were
statistically significant associations between any UI and angina (OR 1.89; 95% CI: 1.22 - 2.93),
homecare (OR 1.72; 95% CI: 1.02 - 2.89), and hospitalization during the last 12 months (OR 1.67;
95% CI: 1.18 - 2.38). In adjusted analyses severe UI was also significantly associated with the same
variables, and also with diabetes drug treatment (OR 2.10; 95% CI: 1.07 - 4.10) and stroke (OR
2.47; 95% CI: 1.09 - 5.59).
Conclusion: No single diabetes related risk factor seems to explain the increased risk for UI
among women with diabetes. However, we found associations between UI and some clinical
correlates of diabetes.
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Background
Recent studies have established that urinary incontinence
(UI) is more prevalent among women with diabetes [1,2],
the UI also seems to be of a different type spectrum [3]
and to be more severe [1,4]. The association between dia-
betes and UI has partly been explained by differences in
non-diabetic factors like age, body mass index (BMI) and
obesity, but still seems to be statistically significant after
adjustment for such factors [5]. Several direct diabetes
related factors could possibly lead to an increased risk for
UI in women with diabetes; examples are hyperglycemia
induced polyuria and damage to nerves and blood vessels
[6,7]. A recently published study of patients with type 2
diabetes, found that the threshold value for women to
develop bladder dysfunction was HbA1c >7% [8].
In a previous paper with data from the EPINCONT study
we found a statistically significant association between
diabetes and UI, with an OR of 1.83 (95% CI: 1.57-2.15)
[5]. The association was still significant after adjusting for
age, BMI, parity and smoking (OR 1.21, 95% CI: 1.01-
1.44). Using the same data set we now present analyses on
how specific factors related to the diabetes disease and its
management may further explain this association
between diabetes and UI.
Methods
The Nord-Trøndelag Health Survey 2 (HUNT 2) was a
cross-sectional survey conducted in the county of Nord-
Trøndelag, Norway, in 1995-97. It was a follow-up study
of a similar survey, HUNT 1, conducted in 1984-86. Nord-
Trøndelag is well suited for surveys like this since its geog-
raphy, demography and inhabitants are fairly representa-
tive for Norway. Nord-Trøndelag, however, has no big
cities, and its inhabitants have an income and educational
level slightly below average.
All the inhabitants aged 20 years or older in the county
were invited to participate (n = 94 197), 47 313 were
women. The invitations mailed to the inhabitants
included questionnaire 1 (Q1), which was answered by
34 755 women. The participants were asked to bring the
completed questionnaire to a screening station, where
among other measurements blood pressure, height and
weight were measured, and blood samples were drawn.
The women who met at the screening station received
questionnaire 2 (Q2), which was different from men, and
which among other topics contained questions on UI.
The incontinence part of the questionnaire is known as
the EPINCONT study (Epidemiology of incontinence in
the county of Nord-Trøndelag) [9]. Urinary incontinence
was defined in accordance with the standards of the Inter-
national Continence Society as "any leakage of urine"
[10]. Type of incontinence was determined by asking the
women about the situations in which they experienced
leakage. If leakage occurred in association with lifting
heavy items, laughing, coughing or sneezing the women
were categorised as having symptoms of stress UI. Leakage
in association with a strong urge to void was categorised
as urge UI. The incontinent women who had both stress
and urge symptoms were classified as having mixed type
incontinence. For a small number of women (19) type
could not be determined due to incomplete answers [9].
The women further answered questions about frequency
of leakage (four levels), and amount of leakage (three lev-
els), which were used to determine Sandvik's severity
index [11]
Q1 also had a question on diabetes status, and those
answering affirmative to the question "Do you have or
have you had diabetes?" received questionnaire 3 (Q3)
containing further questions on their diabetes situation
[12]. This questionnaire contained questions on subjects
like diagnosis, treatment (insulin, tablets, none), moni-
toring of the diabetes (home monitoring, monitored by
health personal), diet, membership in Norwegian Diabe-
tes Association, vision issues, hospitalization since diag-
nosis, quality of life and foot problems. The participants
identified as having diabetes had an additional 5 ml EDTA
blood drawn for HbA1c analysis. They also received three
urine tubes for overnight urine sampling, which were ana-
lysed for microalbuminuria and creatinine to calculate the
albumine:creatinine ratio (ACR). Women who through
Q1 were identified as having diabetes were given new
appointments for fasting serum sample, used for analyses
of glucose, C-peptide and anti-GAD. Anti-GAD was ana-
lysed via immunoprecipitation, using (3H)leucine trans-
lation-labelled GAD65 as an indicator. The women were
cathegorized as having type II DM if concentration of anti-
GAD was below 0.08. Further information about methods
and instruments used for blood-sample analyses are
described elsewhere [12].
Response rate was high, 80% (27 936) of the women
meeting at the screening stations answered the inconti-
nence part of the study, and out of these 75% answered
the questions on diabetes. This provided us with data on
a total of 685 women with diabetes.
Statistics
Data were analysed using SPSS (version 15.0). Statistical
significance was accepted at a 5% level (p < 0.05). We
used Chi-Squared Test to test for differences in prevalence
of diabetes type, non fasting glucose, HbA1c, duration of
diabetes, diabetes treatment, cholesterol value, triglycer-
ide value, albumine: creatinine ratio, oestrogene use,
angina, heart attack, stroke or cerebral hemorrhage, hospi-
talization during the last 12 months and homecare
between women with and without UI. Logistic regressionBMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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analyses were performed to investigate the association
between diabetes-related factors and UI among the
women with diabetes. In a previous study we found that
age, BMI, parity and smoking confounded the association
between diabetes and UI, and these factors were therefore
adjusted for in the final logistic regression analyses also in
the current study [5]. Analyses were performed separately
for each of the different outcomes under investigation,
continent women serving as reference group in all the
analyses. Parity and smoking were categorical variables,
and no children and never smoked were used as alterna-
tive outcomes. Age and BMI were used as continuous var-
iables. Odds ratios with corresponding 95% confidence
intervals (CI) were effect measures. Duration of diabetes
was used as a continuous variable. We chose to use the fol-
lowing variables as categorical, with the following alterna-
tive outcomes: blood glucose < 11.1 mmol/l, HbA1c ≤ 7.0
mmol/l, ACR < 2.5 mg/mmol, cholesterol < 7.7, triglycer-
ide ≤ 2.45, diet treatment, no hospitalization during the
last 12 months, no homecare, no angina, no stroke and
no heart attack.
The women with diabetes categorized into a different type
than type 1 DM and type 2 DM, and those not possible to
categorize due to incomplete data, were added together
into the group "other type of DM" for our analyses in fig-
ure 1.
Ethics
The main study had ethical recommendation from both
the Regional and National Ethics Review Boards. Attend-
ance was completely voluntary and the subjects gave an
extensive written consent to the use of the collected mate-
rial. The survey was also approved by the Norwegian Data
Inspectorate.
Results
Table 1 contains data with respect to several diabetes
related factors for women with and without UI. We found
only a few statistically significant associations between
such factors and UI when performing Chi square tests.
Angina pectoris was significantly more prevalent in the UI
group, and there was also a statistically significant differ-
ence in oestrogene use between the two groups, oestro-
gene use being less prevalent among the incontinent
women. In the UI group a larger proportion had been hos-
pitalized during the last 12 months, and these women
also received more home care services.
Figure 1 shows the distribution of types of UI by types of
DM. Mixed UI was the most common type of UI among
women with type 2 DM and other types of DM, urge UI
was the most common type in women with type 1 DM.
When using Chi square tests to test for differences in type
distribution, the only statistically significant difference
was between type 1 and type 2 diabetes (p = 0.02). Table
2, 3 and 4 show data from logistic regression analyses.
Table 2 contains analyses for any UI and severe UI, whilst
table 3 and 4 contains analyses by type of UI. Table 3
presents unadjusted analyses, whilst table 4 contains the
adjusted analyses. All analyses were adjusted for age, BMI,
parity and smoking. In adjusted analyses any UI was asso-
ciated with angina, home care and hospitalization during
the last 12 months, but not with more direct clinical
related diabetes factors. Severe UI was associated with the
same factors, but in addition also with stroke. Antidia-
betic drug treatment was associated with severe UI only.
In adjusted analyses by UI types the only statistically sig-
nificant associations were between mixed UI and angina,
and between mixed UI and hospitalizations during the
last 12 months. No associations between diabetes man-
agement related factors and type of UI were found.
Discussion
By analyses of this data set we were not able to explain
how specific factors related to the diabetes disease and its
management link diabetes to UI. We found some associa-
tions between diabetes management and complications
and UI, but the biological and laboratory parameters do
not seem to explain the association previously docu-
mented.
The large cross sectional HUNT study had a high response
rate [9]. The UI and DM parts of the study have been val-
idated [11,13,14]. Response rates to the different diabetes
variables varied from 45.5% (health care at home), to
99.7% (glucose, cholesterol and triglycerides), and most
were above 90%. The response rates for individual varia-
bles were similar in women with and without diabetes, so
this should not bias the results. The limited number of
women in some of the analyses might have contributed to
Distribution of UI type by DM type Figure 1








Type 1 (n =9) Type 2 (n = 221) Other (n = 31)
Type of diabetes mellitus
%
Stress UI (n = 71)
Urge UI    (n = 37)
Mixed UI (n = 104)
Other UI  (n = 49)BMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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possible type II errors, but differences in prevalences
between the group with UI and the group without UI were
small. The estimated associations between elevated
HbA1c and severe UI (OR 1.45; 95% CI: 0.85 - 2.47) and
between elevated HbA1c and urge UI (OR 1.79; 95% CI:
0.74 - 4.35) were marked but not statistically significant,
probably due to power limitations. There are therefore
indications in our study that some real connections
between UI and diabetes measurements may indeed be
present.
Table 1: Distribution of diabetes related variables and general health status variables in diabetic women with and without UI (n)
Variable Women without UI
N = 418 (61%)
Women with UI
N = 267 (39%)
P - value
Type diabetes (514) 0.167
Type 1 DM 23 (7.2) 8 (4.1)
Type 2 DM 244 (76.5) 162 (83.1)
Other 52 (16.3) 25 (12.8)
Non-fasting glucose (683) 0.403
< 11.1 mmol/ 310(74.3) 191 (71.8)
≥ 11.1 mmol/l 107(25.7) 75 (28.2)
HbA1c (n = 659) 0.468
≤ 7.0 mmol/l 141 (34.8) 90 (35.4)
> 7.0 mmol/l 264 (65.2) 164 (64.6)
Duration of diabetes (506) 0.364
0 - 10 years 216 (68.6) 123 (64.4)
11 - 20 years 71 (22.5) 55 (28.8)
21 - 30 years 20 (6.3) 8 (4.2)
≥ 31 years 8 (2.5) 5 (2.6)
Diabetes treatment (510) 0.542
Drugs 213 (67.8) 138 (70.4)
Diet only 101 (32.2) 58 (29.6)
Cholesterol (683) 0.906
< 7.7 mmol/l 345 (82.7) 221 (83.1)
≥ 7.7 mmol/l 72 (17.3) 45 (16.9)
Triglycerides (683) 0.855
≤ 2.45 mmol/l 260 (62.4) 164 (61.7)
> 2.45 mmol/l 157 (37.6) 102 (38.3)
ACR (617) 0.489
< 2.5 mmol/l 309 (81.7) 190 (79.5)
≥ 2.5 mmol/l 69 (18.3) 49 (20.5)
Estrogene use (oral or patch) (492) 0.012
Using now 29 (9.3) 30 (16.8)
Used before 16 (5.1) 15 (8.4)
Never used 268 (85.6) 134 (74.9)
Estrogene use (local) (455) < 0.001
Using now 30 (10.6) 33 (19.3)
Used before 12 (4.2) 19 (11.1)
Never used 242 (85.2) 119 (69.6)
Angina (668) < 0.001
No 347 (85.0) 190 (73.1)
Yes 61 (15.0) 70 (26.9)
Heart attack (671) 0.094
No 385 (93.9) 236 (90.4)
Yes 25 (6.1) 25 (9.6)
Stroke (663) 0.072
No 385 (95.3) 238 (91.9)
Yes 19 (4.7) 21 (8.1)
Hospitalization during last 12 months (653) 0.001
No 232 (58.1) 114 (44.9)
Yes 167 (41.9) 140 (55.1)
Home care (373) < 0.001
No 146 (69.9) 82 (50.0)
Yes 63 (30.1) 82 (50.0)BMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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Previous studies have found correlations between diabe-
tes and UI [1,2,5]. Intensive lifestyle intervention was
found to reduce the risk of developing DM in women with
increased fasting levels of glucose, and also to reduce inci-
dence of UI compared to a metformin treated group and
a placebo treated group [15]. The authors showed that
reduced weight in the lifestyle intervention group
explained most of the effect, and that direct DM related
factors played a minor role for the effect on UI.
That HbA1c (> 7 mmol/l) was not associated with an
increased risk for UI in women with diabetes, is in accord-
ance with findings from a recent study on bladder dys-
functions in type 2 diabetes patients [8], also stating,
however, that HbA1c was positively correlated with an
increase in volume at first desire to void, and mean HbA1c
was found to be higher in women with post-void residual
volume > 100 ml.
Diabetes complications increase in prevalence with the
duration of diabetes. One would therefore expect a corre-
lation between diabetes duration and UI. Assuming that
UI could be caused by alteration of the detrusor muscle,
the innervation or function of the neuronal component or
urothelial dysfunction [16], high levels of glucose over
time could be partially responsible for such damage.
However, we found no such significant association
between duration, blood glucose, HbA1c and UI in our
study, and adjustments for age did not change this. But
the significant correlation between medical treatment for
DM (hence more serious DM) and severe UI, may anyhow
indicate that clinical complications may have an impact
on the risk of UI after longstanding disease.





Unadjusted Adjusted † Unadjusted Adjusted †
Glucose
< 11.1 mmol/l 1.0 1.0 1.0 1.0
≥ 11.1 mmol/l 1.14 (0.81 - 1.61) 0.97 (0.66 - 1.42) 1.77 (1.15 - 2.73)* 1.53 (0.94 - 2.47)
HbA1c
≤ 7.0 mmol/l 1.0 1.0 1.0 1.0
> 7.0 mmol/l 0.97 (0.70 - 1.35) 0.92 (0.64 - 1.34) 1.49 (0.94 - 2.37) 1.45 (0.85 - 2.47)
Duration of diabetes 1.01 (0.99 - 1.03) 1.00 (0.98 - 1.03) 1.01 (0.98 - 1.04) 1.00 (0.97 - 1.04)
Diabetes treatment
Diet only 1.0 1.0 1.0 1.0
Drugs (insulin or tablets) 1.13 (0.77 - 1.66) 1.0 (0.65 - 1.55) 1.94 (1.09 - 3.47)* 2.10 (1.07 - 4.10)*
ACR
< 2.5 mmol/l 1.0 1.0 1.0 1.0
≥ 2.5 mmol/l 1.16 (0.77 - 1.74) 1.02 (0.65 - 1.61) 1.33 (0.78 - 2.26) 1.00 (0.55 - 1.85)
Triglycerides
≤ 2.45 mmol/l 1.0 1.0 1.0 1.0
> 2.45 mmol/l 1.03 (0.75 - 1.41) 0.79 (0.56 - 1.13) 1.24 (0.82 - 1.88) 1.09 (0.69 - 1.73)
Cholesterol
< 7.7 mmol/l 1.0 1.0 1.0 1.0
≥ 7.7 mmol/l 0.98 (0.65 - 1.47) 0.91 (0.59 - 1.43) 1.06 (0.62 - 1.80) 0.91 (0.50 - 1.65)
Angina
No 1.0 1.0 1.0 1.0
Yes 2.10 (1.42 - 3.08)*** 1.89 (1.22 - 2.93)** 2.36 (1.48 - 3.79)*** 2.05 (1.20 - 3.48)**
Heart attack
No 1.0 1.0 1.0 1.0
Yes 1.63 (0.92 - 2.91) 1.31 (0.68 - 2.54) 2.22 (1.11 - 4.42)* 1.69 (0.76 - 3.75)
Stroke
No 1.0 1.0 1.0 1.0
Yes 1.79 (0.94 - 3.40) 1.84 (0.91 - 3.73) 2.97 (1.44 - 6.13)** 2.47 (1.09 - 5.59)*
Home care
No 1.0 1.0 1.0 1.0
Yes 2.32 (1.51 - 3.55)*** 1.72 (1.02 - 2.89)* 3.57 (2.12 - 6.00)*** 2.80 (1.48 - 5.29)**
Hospitalization during last 12 months
No 1.0 1.0 1.0 1.0
Yes 1.71 (1.24 - 2.34)** 1.67 (1.18 - 2.38)** 2.41 (1.57 - 3.71)*** 2.55 (1.56 - 4.16)***
† = adjusted for age, BMI, parity and smoking. * = p < 0.05 ** = p < 0.01 *** = p < 0.001BMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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An increased rate of hospitalization during the last 12
months indicates that women with DM and UI had a
worse health status than women without UI. In our previ-
ous study from the same data set we found that women
with diabetes had significantly higher prevalence of
stroke, heart attack and elevated blood pressure [5]. In the
present analysis the diabetic women with UI had signifi-
cantly more angina than the women without UI, indicat-
ing a higher prevalence of cardiovascular problems in the
diabetic women with UI. If such disease mechanisms also
occur in other organs, inadequate vascularisation of the
bladder might contribute to a higher prevalence of UI in
women with diabetes. Microvascular changes may dam-
age the innervation of the bladder, alter detrusor muscle
function or cause impaired bladder sensation as well as
overflow incontinence [17]. Poor health status in elderly
patients with diabetes is common. Women with diabetes
have higher rates of many chronic diseases, like stroke,
kidney disease and chronic heart failure, are less likely to
rate their health as good or excellent and they report
greater functional disability [18]. Poorly regulated diabe-
tes is shown to be an important determinant for develop-
ing diabetic autonome neuropathy, and autonomic
function has been shown to be more abnormal in insulin-
dependent diabetic patients with coronary heart disease
than those without [19]. We are fully aware of, however,
that our cross sectional study design cannot establish cau-
sality between risk factors and outcomes.
The nonsignificant findings of our study could be due to
lack of relevant variables in order to determine an actual
connection between DM and UI. If a causal mechanism by
neuropathy or microvascular changes is the explanation,
we would need more relevant variables including detailed








< 11.1 mmol/l 1.0 1.0 1.0
≥ 11.1 mmol/l 0.96 (0.55 - 1.69) 1.57 (0.81 - 3.06) 1.30 (0.84 - 2.01)
HbA1c
≤ 7.0 mmol/l 1.0 1.0 1.0
> 7.0 mmol/l 0.72 (0.44 - 1.19) 1.97 (0.92 - 4.23) 0.96 (0.63 - 1.47)
Duration of diabetes 0.97 (0.93 - 1.01) 1.03 (1.00 - 1.07) 1.02 (0.99 - 1.04)
Diabetes treatment
Diet only 1.0 1.0 1.0
Drugs 0.88 (0.48 - 1.61) 1.99 (0.79 - 4.99) 1.18 (0.71 - 1.93)
ACR
< 2.5 mmol/l 1.0 1.0 1.0
≥ 2.5 mmol/l 0.84 (0.42 - 1.68) 1.22 (0.56 - 2.67) 1.17 (0.70 - 1.96)
Triglycerid
≤ 2.45 mmol/l 1.0 1.0 1.0
> 2.45 mmol/l 0.80 (0.48 - 1.33) 1.19 (0.63 - 2.25) 1.11 (0.74 - 1.67)
Cholesterol
< 7.7 mmol/l 1.0 1.0 1.0
≥ 7.7 mmol/l 0.78 (0.39 - 1.54) 0.61 (0.23 - 1.61) 0.98 (0.58 - 1.65)
Angina
No 1.0 1.0 1.0
Yes 1.04 (0.53 - 2.04) 1.25 (0.55 - 2.82) 2.56 (1.62 - 4.04)***
Heart attack
No 1.0 1.0 1.0
Yes 1.28 (0.51 - 3.21) 0.35 (0.05 - 2.67) 2.11 (1.10 - 4.05)*
Stroke
No 1.0 1.0 1.0
Yes 1.15 (0.38 - 3.48) 2.58 (0.92 - 7.26) 1.89 (0.88 - 4.06)
Home care
No 1.0 1.0 1.0
Yes 2.27 (1.16 - 4.44)* 2.44 (1.11 - 5.33)* 2.22 (1.31 - 3.76)**
Hospitalization during last 12 months
No 1.0 1.0 1.0
Yes 1.38 (0.84 - 2.25) 1.22 (0.64 - 2.30) 1.85 (1.22 - 2.80)**
* = p < 0.05 ** = p < 0.01 *** = p < 0.001
‡ = There is a small discrepancy in number of women in the any UI group and UI type groups because type could not be determined in all of the 
women with UI due to incomplete answers.BMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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bladder function tests to identify damages caused by DM,
and also more sophisticated ways of estimating neuropa-
thy. Kaplan et al emphasize the importance of urody-
namic studies in diagnosing voiding dysfunction in
diabetic patients, especially to separate UI, cancer or uri-
nary tract infections from diabetic cystopathy [20]. Clini-
cal examinations are costly and difficult to perform as part
of epidemiological studies, due to a large number of par-
ticipants needed, and it is also likely that it would be more
difficult to recruit participants to clinical examinations in
this field. Future studies should include questions that
could possibly replace physical examinations.
The strongest association between diabetes and UI pre-
sented in our previous publication was between diabetes
and severe UI [5]. The small number of women with
severe UI might partly explain why no significant associa-
tions were found between the diabetes related factors and
severe UI. Only 43 women with severe UI had blood glu-
cose >11.1 mmol/l which might explain why the associa-
tion after adjustments no longer was significant.
Studies on rats with induced diabetes have found several
possible explanations for bladder problems due to diabe-
tes. Paro et al demonstrated a doubling of the threshold
volume required to initiate the micturition reflex in rats
with diabetes for 8 months [21]. They also found changes
in pelvic and hypogastric nerves. Treatment with ganglio-
sides within 4 months could to a large extent reverse these
damages. Another study showed that diabetes led to up-
regulation of muscarine-acetylcholine receptors in the uri-
nary bladder, which could lead to increased reactivity to








< 11.1 mmol/l 1.0 1.0 1.0
≥ 11.1 mmol/l 0.84 (0.45 - 1.56) 1.17 (0.53 - 2.60) 1.17 (0.71 - 1.86)
HbA1c
≤ 7.0 mmol/l 1.0 1.0 1.0
> 7.0 mmol/l 0.69 (0.40 - 1.20) 1.79 (0.74 - 4.35) 0.90 (0.55 - 1.47)
Duration of diabetes 0.95 (0.91 - 1.00) 1.03 (0.99 - 1.08) 1.02 (0.99 - 1.05)
Diabetes treatment
Diet only 1.0 1.0 1.0
Drugs 0.77 (0.40 - 1.50) 2.67 (0.87 - 8.25) 1.01 (0.57 - 1.78)
ACR
< 2.5 mmol/l 1.0 1.0 1.0
≥ 2.5 mmol/l 0.66 (0.30 - 1.48) 1.24 (0.50 - 3.09) 1.07 (0.60 - 1.93)
Triglycerid
≤ 2.45 mmol/l 1.0 1.0 1.0
> 2.45 mmol/l 0.61 (0.34 - 1.09) 1.12 (0.53 - 2.34) 0.83 (0.53 - 1.32)
Cholesterol
< 7.7 mmol/l 1.0 1.0 1.0
≥ 7.7 mmol/l 0.87 (0.43 - 1.78) 0.59 (0.20 - 1.75) 0.80 (0.44 - 1.46)
Angina
No 1.0 1.0 1.0
Yes 1.22 (0.58 - 2.55) 0.92 (0.33 - 2.59) 2.25 (1.34 - 3.77)**
Heart attack
No 1.0 1.0 1.0
Yes 1.03 (0.34 - 3.13) NA 1.61 (0.75 - 3.45)
Stroke
No 1.0 1.0 1.0
Yes 1.33 (0.42 - 4.18) 1.78 (0.47 - 6.71) 1.89 (0.82 - 4.36)
Home care
No 1.0 1.0 1.0
Yes 1.78 (0.76 - 4.14) 2.09 (0.79 - 5.54) 1.68 (0.89 - 3.17)
Hospitalization during last 12 months
No 1.0 1.0 1.0
Yes 1.33 (0.77 - 2.30) 1.44 (0.69 - 3.03) 1.74 (1.10 - 2.78)*
* = p < 0.05 ** = p < 0.01 *** = p < 0.001 NA = Not applicable due to no cases
† = Adjusted for age, BMI, parity and smoking
‡ = There is a small discrepancy in number of women in the any UI group UI type groups because type of UI could not be determined in all of the 
women with UI due to incomplete answers.BMC Urology 2009, 9:11 http://www.biomedcentral.com/1471-2490/9/11
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acetylcholine and result in detrusor instability [22]. Even
if diabetes causes the same changes in the human bladder,
epidemiological studies are probably not the best study
design to study such connections. This may explain why
our previous epidemiological study found a higher preva-
lence of UI [5], while no diabetes related risk factors in the
present study seem to be able to explain the findings.
Conclusion
No single diabetes related risk factor seems to explain the
increased risk for UI among women with diabetes. How-
ever, we found associations between UI and some clinical
correlates of diabetes. Further epidemiological studies
may not be the best strategy to study the mechanisms of
increased risk of UI among women with DM.
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